About
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Key Metrics
as of Sep 2026Market Cap36,566 Cr
P/E35.50
Div Yield0.19 %
Book Value₹261.00
52w High₹2,048.00
52w Low₹1,260.00
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,451.00 | 1,468.00 | 1,418.00 | 1,261.00 | 1,097.00 | 1,278.00 | 1,029.00 | 1,105.00 | 970.00 | 903.00 | 870.00 | 888.00 |
| Expenses | 1,111.00 | 1,096.00 | 1,118.00 | 1,036.00 | 869.00 | 1,034.00 | 904.00 | 947.00 | 855.00 | 796.00 | 746.00 | 788.00 |
| Operating Profit | 340.00 | 372.00 | 300.00 | 225.00 | 228.00 | 245.00 | 124.00 | 158.00 | 115.00 | 106.00 | 124.00 | 100.00 |
| OPM % | 23.00 | 25.00 | 21.00 | 18.00 | 21.00 | 19.00 | 12.00 | 14.00 | 12.00 | 12.00 | 14.00 | 11.00 |
| Other Income | 25.00 | 35.00 | 109.00 | 23.00 | 18.00 | 22.00 | 19.00 | 49.00 | 33.00 | 25.00 | 33.00 | 30.00 |
| Depreciation | 63.00 | 63.00 | 62.00 | 62.00 | 60.00 | 57.00 | 57.00 | 56.00 | 55.00 | 56.00 | 54.00 | 48.00 |
| Interest | 33.00 | 37.00 | 33.00 | 28.00 | 21.00 | 24.00 | 20.00 | 31.00 | 38.00 | 39.00 | 42.00 | 46.00 |
| Profit before tax | 269.00 | 306.00 | 314.00 | 158.00 | 166.00 | 186.00 | 67.00 | 119.00 | 55.00 | 35.00 | 61.00 | 36.00 |
| Tax % | 26.00 | 24.00 | 18.00 | 26.00 | 26.00 | 25.00 | 25.00 | 27.00 | 27.00 | 18.00 | 20.00 | 24.00 |
| Net Profit | 200.00 | 234.00 | 259.00 | 118.00 | 123.00 | 140.00 | 50.00 | 87.00 | 40.00 | 29.00 | 48.00 | 27.00 |
| EPS in Rs | 10.55 | 12.33 | 13.65 | 6.20 | 6.48 | 7.37 | 2.65 | 4.60 | 2.23 | 1.60 | 2.67 | 1.51 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5,243.00 | 4,382.00 | 3,498.00 | 3,107.00 | 3,387.00 | 3,154.00 | 2,376.00 | 2,454.00 |
| Expenses | 4,220.00 | 3,759.00 | 3,056.00 | 2,668.00 | 2,593.00 | 2,410.00 | 1,948.00 | 1,883.00 |
| Operating Profit | 1,023.00 | 623.00 | 442.00 | 439.00 | 795.00 | 743.00 | 428.00 | 570.00 |
| OPM % | 20.00 | 14.00 | 13.00 | 14.00 | 23.00 | 24.00 | 18.00 | 23.00 |
| Other Income | 286.00 | 142.00 | 129.00 | 119.00 | 133.00 | 94.00 | 89.00 | 56.00 |
| Interest | 118.00 | 113.00 | 166.00 | 167.00 | 145.00 | 123.00 | 137.00 | 127.00 |
| Depreciation | 247.00 | 225.00 | 205.00 | 179.00 | 166.00 | 156.00 | 155.00 | 130.00 |
| Profit before tax | 944.00 | 428.00 | 200.00 | 212.00 | 616.00 | 557.00 | 225.00 | 370.00 |
| Tax % | 22.00 | 26.00 | 20.00 | 25.00 | 28.00 | 25.00 | 22.00 | 23.00 |
| Net Profit | 733.00 | 317.00 | 161.00 | 160.00 | 447.00 | 420.00 | 175.00 | 284.00 |
| EPS in Rs | 38.66 | 16.74 | 8.88 | 8.85 | 24.71 | 23.25 | 9.69 | 15.68 |
| Dividend Payout % | 9.00 | 18.00 | 23.00 | 23.00 | 12.00 | 4.00 | 26.00 | 16.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 190.00 | 189.00 | 181.00 | 181.00 | 181.00 | 181.00 | 181.00 | 181.00 |
| Reserves | 3,521.00 | 2,835.00 | 1,754.00 | 1,661.00 | 1,532.00 | 2,121.00 | 1,734.00 | 1,597.00 |
| Borrowings | 1,597.00 | 857.00 | 1,595.00 | 1,773.00 | 1,579.00 | 1,665.00 | 1,243.00 | 1,224.00 |
| Other Liabilities | 1,607.00 | 1,534.00 | 1,226.00 | 1,001.00 | 1,032.00 | 897.00 | 713.00 | 576.00 |
| Total Liabilities | 6,914.00 | 5,416.00 | 4,757.00 | 4,616.00 | 4,323.00 | 4,863.00 | 3,871.00 | 3,578.00 |
| Fixed Assets | 1,754.00 | 1,759.00 | 1,718.00 | 1,433.00 | 1,151.00 | 1,278.00 | 1,166.00 | 1,100.00 |
| CWIP | 122.00 | 99.00 | 106.00 | 253.00 | 239.00 | 192.00 | 326.00 | 406.00 |
| Investments | 1,424.00 | 678.00 | 684.00 | 690.00 | 563.00 | 864.00 | 408.00 | 311.00 |
| Other Assets | 3,614.00 | 2,880.00 | 2,248.00 | 2,240.00 | 2,369.00 | 2,529.00 | 1,971.00 | 1,761.00 |
| Total Assets | 6,914.00 | 5,416.00 | 4,757.00 | 4,616.00 | 4,323.00 | 4,863.00 | 3,871.00 | 3,578.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 424.00 | 558.00 | 585.00 | 505.00 | 428.00 | 775.00 | 385.00 | 371.00 |
| Cash from Investing Activity | -947.00 | -438.00 | -173.00 | -271.00 | -394.00 | -836.00 | -169.00 | -276.00 |
| Cash from Financing Activity | 526.00 | -49.00 | -288.00 | -55.00 | -343.00 | 31.00 | -46.00 | -53.00 |
| Net Cash Flow | 3.00 | 71.00 | 124.00 | 180.00 | -309.00 | -30.00 | 170.00 | 42.00 |
| Free Cash Flow | 178.00 | 378.00 | 342.00 | 225.00 | 243.00 | 677.00 | 287.00 | 85.00 |
| CFO/OP % | 63.00 | 100.00 | 148.00 | 134.00 | 75.00 | 120.00 | 97.00 | 87.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107.00 | 99.00 | 115.00 | 124.00 | 109.00 | 116.00 | 175.00 | 135.00 |
| Inventory Days | 197.00 | 189.00 | 206.00 | 214.00 | 202.00 | 182.00 | 200.00 | 243.00 |
| Days Payable | 186.00 | 204.00 | 220.00 | 203.00 | 166.00 | 168.00 | 197.00 | 159.00 |
| Cash Conversion Cycle | 118.00 | 84.00 | 101.00 | 135.00 | 144.00 | 130.00 | 177.00 | 220.00 |
| Working Capital Days | 53.00 | 61.00 | -4.00 | 0.00 | 17.00 | 19.00 | 60.00 | 50.00 |
| ROCE % | 24.00 | 14.00 | 10.00 | 11.00 | 21.00 | 20.00 | 13.00 | — |
Corporate Actions
1 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 14 Aug 2025 | 14 Aug 2025 | — | 3.00 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update31 Aug from care
-
Rating update5 Dec 2025 from crisil
-
Rating update17 Oct 2025 from crisil
-
Rating update7 Oct 2025 from care
-
Rating update6 Nov 2024 from crisil
-
Rating update12 Aug 2024 from care